A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer - Wikidata - wikimedia - TriplyDB

A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer

A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer

http://www.wikidata.org/entity/Q34192568

about

Patient-derived tumour xenografts as models for oncology drug development Patient-derived tumor xenografts: transforming clinical samples into mouse models An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts Precision medicine for cancer with next-generation functional diagnostics Colorectal cancer models for novel drug discovery Predictive biomarkers in precision medicine and drug development against lung cancer Early phase clinical trials to identify optimal dosing and safety Prospects and pitfalls of personalizing therapies for sarcomas: from children, adolescents, and young adults to the elderly Current status and evolution of preclinical drug development models of epithelial ovarian cancer Influence of handling conditions on the establishment and propagation of head and neck cancer patient derived xenografts Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures Pharmacogenetics and pharmacogenomics as tools in cancer therapy Organoid development in cancer genome discovery Getting personalized cancer genome analysis into the clinic: the challenges in bioinformatics Development and histopathological characterization of tumorgraft models of pancreatic ductal adenocarcinoma Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancers Integrated analysis of transcriptome in cancer patient-derived xenografts Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer.Personalized chemotherapy profiling using cancer cell lines from selectable mice The future of patient-derived tumor xenografts in cancer treatment.Miniaturized pre-clinical cancer models as research and diagnostic tools.Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition.Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis.Ex vivo tumor culture systems for functional drug testing and therapy response prediction Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations.In vitro and in vivo activity of the low-immunogenic antimesothelin immunotoxin RG7787 in pancreatic cancer.Patient-derived xenograft models: an emerging platform for translational cancer research Patient-derived xenografts for individualized care in advanced sarcoma.The promise of patient-derived xenografts: the best laid plans of mice and men Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions.Establishment of genetically diverse patient-derived xenografts of colorectal cancer.Melanoma genotypes and phenotypes get personal.Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer.Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment.Tissue slice grafts of human renal cell carcinoma: an authentic preclinical model with high engraftment rate and metastatic potential.Development of a realistic in vivo bone metastasis model of human renal cell carcinoma Human cancer growth and therapy in immunodeficient mouse models.Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraft An orthotopic model of platinum-sensitive high grade serous fallopian tube carcinoma Discovery of a drug targeting microenvironmental support for lymphoma cells by screening using patient-derived xenograft cells

P2860

Q24604068-86C2ECA7-45DF-4E92-904A-BFA2E8701686 Q24627425-4F5645FB-8D63-4409-B4D6-F35A95F90654 Q26772895-9C9A0FB8-B360-45AA-A908-E74165AD4618 Q26780232-688FC7C3-1825-4D5E-988D-940179619B59 Q26795724-41CDAB9C-7F57-40F2-BD1C-69C35D168396 Q26824536-0D691F58-28DD-458A-AFC7-B9CCFDF94424 Q26865076-62FA86E3-C605-46CC-84C9-DF1FAE4F0605 Q27025344-BD878028-29ED-4099-8D67-2A51A800E34D Q27028117-8C178A8B-FC29-4BA5-822D-7339DCA4FBD9 Q27321370-A0E0903F-F8F3-4A97-9B91-1F5FE998D40B Q27324252-63A34CE0-8115-40A4-86A5-767F29A023C4 Q28076200-A3000B1B-DBCD-469A-B498-38F5E481C480 Q28083032-F3147758-B459-48B5-BEDB-D5FA3CE473C8 Q28394818-A674FF00-835F-4AF2-81A4-3360828C90A3 Q28534618-EF5C6BB6-C937-48B7-B6B0-DFFA4FC06C99 Q28545204-262FEC2F-8780-466D-8CD8-CBFDFFF8D102 Q28547069-F359D8EB-F101-4156-A469-DA71CCD20506 Q30423597-3FEE8F8F-109A-46A3-BF2F-15EBAA46FAE7 Q30538234-4911F3AA-BB8D-4DBC-8680-D4D9A22B06FA Q33361578-408F9406-7B42-4C0B-A190-113652BB96F3 Q33605145-98F2D3B0-03D1-4D01-918E-A0A6A08B2EFF Q33739184-01798426-8536-48BA-BA01-14D7AB302D91 Q33761491-8904E78D-6BEF-4237-BD7F-B7190BE77E15 Q33827247-0F5AB023-3F29-4B08-B7F3-AEE58BCC58CD Q34017017-1ED2A54F-AE3E-4EA2-9007-5F9A756E9484 Q34080906-3D00A3B6-AC0A-4679-BCDB-BB62A8ECD674 Q34205518-4357C020-5EBF-41C9-AA84-409B3AC3FD11 Q34413869-CD43CFD6-0B6C-4B1D-B805-ECF522FE9222 Q34443008-9BA1FA87-BFC7-42C4-8C9B-4144F88CD323 Q34654508-26C6F24B-FF20-448F-BD9B-AA3E7EADB694 Q34704942-33BA396F-407C-442A-BD2C-2499E922AEF6 Q34788817-E7012A67-31AB-4D3F-9B68-A637F0E856F4 Q34994030-85850D08-1F20-498C-A4F8-C4B94B5F753F Q35067532-7A9DEE22-90FA-4CCF-B565-F8DDD18F538D Q35150788-846E2AB2-B183-4B9C-B464-1A0CC629CD33 Q35154534-F1C5AAFA-4A8E-49CF-BE42-ABB2395AE2C6 Q35545282-F771C4BA-8E41-498A-8F5E-036BEBAB7BAD Q35592388-5B236EE9-CA37-4109-BF97-B80005B95F49 Q35702786-55E2A707-DFBE-4472-B711-7FB652856D80 Q35747414-2D3D552C-AFA5-4821-B480-3A0B7E17D876

P2860

A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer

http://www.wikidata.org/entity/Q34192568

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

A pilot clinical study of trea ...... patients with advanced cancer

@ast

A pilot clinical study of trea ...... patients with advanced cancer

@en

A pilot clinical study of trea ...... patients with advanced cancer

@nl

type

label

A pilot clinical study of trea ...... patients with advanced cancer

@ast

A pilot clinical study of trea ...... patients with advanced cancer

@en

A pilot clinical study of trea ...... patients with advanced cancer

@nl

prefLabel

A pilot clinical study of trea ...... patients with advanced cancer

@ast

A pilot clinical study of trea ...... patients with advanced cancer

@en

A pilot clinical study of trea ...... patients with advanced cancer

@nl

P1433

Q34192568-3273F453-DDA6-40E8-9F03-408D6D5B86B3

P1476

Q34192568-40FF6A0F-2928-4816-A994-5EA9BE135E92

P2093

Q34192568-060D7C49-4857-482D-9B65-6683674F8A37

Q34192568-15E783EE-BB18-4C31-8C8A-94BD4B52785D

Q34192568-46560663-CF0D-4F83-ADD6-05D18F49AB07

Q34192568-5D37E836-02BA-40CB-9490-152D8FD74F61

Q34192568-72259631-50A3-4606-8A0C-6AE2B126CCE4

Q34192568-96C67023-4196-408A-8C45-F66008ACCBA0

Q34192568-C0560CB6-5662-4D45-BE18-CBFAA429230E

Q34192568-D3482E5C-2E0F-44E4-8B7E-2CD0B2B63296

Q34192568-F9602CF5-03CE-487E-B7F8-1B9E39615139

P2860

Q34192568-017DDDF8-4591-4923-8484-2021C9F30C92

Q34192568-0E558E3A-D80A-48A3-91B0-38F763AA2469

Q34192568-10DCF599-80EC-49FE-AF2B-3684804A4779

Q34192568-290CF402-D456-49BE-8450-2D7E1CA66A98

Q34192568-30A9140A-ED17-4D4A-8DF1-70285E067CF5

Q34192568-47DD32EF-AB3F-4D56-B607-C3542D1B0FF3

Q34192568-532B84CE-DD55-4AE1-A665-3447043E2E70

Q34192568-7B8E7975-CCD9-4214-8521-08A193E3F9A5

Q34192568-AD758AD8-C774-4B01-8389-9BEC8F7A277D

Q34192568-D200A541-3785-499A-994F-BA919F6D1E3D

P304

Q34192568-A86DB927-9F79-4C5F-A25E-FFC0BAA21B13

P31

Q34192568-4BF8AC06-9F33-40EE-BFA8-8DC8558151AC

P356

Q34192568-24293723-A2A2-441E-A521-95F5A1C2C6E9

P433

Q34192568-6D8269ED-22D4-4480-8D5C-6CF2C254CF57

P478

Q34192568-00B4D166-A8C0-488F-BA8D-20FB42EDA646

P50

Q34192568-D6C4A70C-DD1D-417C-B842-E6413882982D

P577

Q34192568-3D3F6A81-6D24-4B81-9633-FE26116A05EE

P698

Q34192568-D29EB712-3F37-4DD7-BAC9-C5AABD658906

P921

Q34192568-EAEA0FC8-BF28-4768-8B7C-4AD742DBABB3

P932

Q34192568-72D0C67F-C031-43C3-94FF-215955B74085

P356

1535-7163.MCT-11-0233

P1433

Molecular Cancer Therapeutics

P1476

A pilot clinical study of trea ...... patients with advanced cancer

@en

P2093

Belen Rubio-Viqueira

http://www.w3.org/2001/XMLSchema#string

David Sidransky

http://www.w3.org/2001/XMLSchema#string

Elizabeth Bruckheimer

http://www.w3.org/2001/XMLSchema#string

Elizabeth De Oliveira

http://www.w3.org/2001/XMLSchema#string

James Martell

http://www.w3.org/2001/XMLSchema#string

Manuel Hidalgo

http://www.w3.org/2001/XMLSchema#string

Michael J Wick

http://www.w3.org/2001/XMLSchema#string

N V Rajeshkumar

http://www.w3.org/2001/XMLSchema#string

Steven Strawn

http://www.w3.org/2001/XMLSchema#string

P2860

Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene

Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer

Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selection.

Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts.

Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy.

Risks and benefits of phase 1 oncology trials, 1991 through 2002.

P304

1311-1316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1535-7163.MCT-11-0233

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Ignacio Garrido-Laguna

P577

2011-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21673092

http://www.w3.org/2001/XMLSchema#string

P921

P932

4629061

http://www.w3.org/2001/XMLSchema#string